Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 29

1.

Nanoscale organization of tetraspanins during HIV-1 budding by correlative dSTORM/AFM.

Dahmane S, Doucet C, Le Gall A, Chamontin C, Dosset P, Murcy F, Fernandez L, Salas D, Rubinstein E, Mougel M, Nollmann M, Milhiet PE.

Nanoscale. 2019 Mar 28;11(13):6036-6044. doi: 10.1039/c8nr07269h.

PMID:
30869094
2.

In cell mutational interference mapping experiment (in cell MIME) identifies the 5' polyadenylation signal as a dual regulator of HIV-1 genomic RNA production and packaging.

Smyth RP, Smith MR, Jousset AC, Despons L, Laumond G, Decoville T, Cattenoz P, Moog C, Jossinet F, Mougel M, Paillart JC, von Kleist M, Marquet R.

Nucleic Acids Res. 2018 May 18;46(9):e57. doi: 10.1093/nar/gky152.

3.

Current Peptide and Protein Candidates Challenging HIV Therapy beyond the Vaccine Era.

Chupradit K, Moonmuang S, Nangola S, Kitidee K, Yasamut U, Mougel M, Tayapiwatana C.

Viruses. 2017 Sep 29;9(10). pii: E281. doi: 10.3390/v9100281. Review.

4.

Sensing of HIV-1 Entry Triggers a Type I Interferon Response in Human Primary Macrophages.

Decalf J, Desdouits M, Rodrigues V, Gobert FX, Gentili M, Marques-Ladeira S, Chamontin C, Mougel M, Cunha de Alencar B, Benaroch P.

J Virol. 2017 Jul 12;91(15). pii: e00147-17. doi: 10.1128/JVI.00147-17. Print 2017 Aug 1.

5.

From Cells to Virus Particles: Quantitative Methods to Monitor RNA Packaging.

Ferrer M, Henriet S, Chamontin C, Lainé S, Mougel M.

Viruses. 2016 Aug 22;8(8). pii: E239. doi: 10.3390/v8080239. Review.

6.

Imaging HIV-1 RNA dimerization in cells by multicolor super-resolution and fluctuation microscopies.

Ferrer M, Clerté C, Chamontin C, Basyuk E, Lainé S, Hottin J, Bertrand E, Margeat E, Mougel M.

Nucleic Acids Res. 2016 Sep 19;44(16):7922-34. doi: 10.1093/nar/gkw511. Epub 2016 Jun 8.

7.

Requirements for nucleocapsid-mediated regulation of reverse transcription during the late steps of HIV-1 assembly.

Racine PJ, Chamontin C, de Rocquigny H, Bernacchi S, Paillart JC, Mougel M.

Sci Rep. 2016 Jun 7;6:27536. doi: 10.1038/srep27536.

8.

Insights into the nuclear export of murine leukemia virus intron-containing RNA.

Pessel-Vivares L, Houzet L, Lainé S, Mougel M.

RNA Biol. 2015;12(9):942-9. doi: 10.1080/15476286.2015.1065375. Review.

9.

HIV-1 nucleocapsid and ESCRT-component Tsg101 interplay prevents HIV from turning into a DNA-containing virus.

Chamontin C, Rassam P, Ferrer M, Racine PJ, Neyret A, Lainé S, Milhiet PE, Mougel M.

Nucleic Acids Res. 2015 Jan;43(1):336-47. doi: 10.1093/nar/gku1232. Epub 2014 Dec 8.

10.

MLV requires Tap/NXF1-dependent pathway to export its unspliced RNA to the cytoplasm and to express both spliced and unspliced RNAs.

Pessel-Vivares L, Ferrer M, Lainé S, Mougel M.

Retrovirology. 2014 Mar 5;11:21. doi: 10.1186/1742-4690-11-21.

11.

MoMuLV and HIV-1 nucleocapsid proteins have a common role in genomic RNA packaging but different in late reverse transcription.

Chamontin C, Yu B, Racine PJ, Darlix JL, Mougel M.

PLoS One. 2012;7(12):e51534. doi: 10.1371/journal.pone.0051534. Epub 2012 Dec 7.

12.

A pyrophosphatase activity associated with purified HIV-1 particles.

Ducloux C, Mougel M, Goldschmidt V, Didierlaurent L, Marquet R, Isel C.

Biochimie. 2012 Dec;94(12):2498-507. doi: 10.1016/j.biochi.2012.06.025. Epub 2012 Jul 3.

PMID:
22766015
13.

Cell biology of retroviral RNA packaging.

Jouvenet N, Lainé S, Pessel-Vivares L, Mougel M.

RNA Biol. 2011 Jul-Aug;8(4):572-80. doi: 10.4161/rna.8.4.16030. Epub 2011 Jul 1. Review.

14.

In vitro and in vivo cleavage of HIV-1 RNA by new SOFA-HDV ribozymes and their potential to inhibit viral replication.

Lainé S, Scarborough RJ, Lévesque D, Didierlaurent L, Soye KJ, Mougel M, Perreault JP, Gatignol A.

RNA Biol. 2011 Mar-Apr;8(2):343-53. Epub 2011 Mar 1.

PMID:
21422817
15.

Murine leukemia virus RNA dimerization is coupled to transcription and splicing processes.

Maurel S, Mougel M.

Retrovirology. 2010 Aug 5;7:64. doi: 10.1186/1742-4690-7-64.

16.

Implications of the nucleocapsid and the microenvironment in retroviral reverse transcription.

Mougel M, Cimarelli A, Darlix JL.

Viruses. 2010 Apr;2(4):939-60. doi: 10.3390/v2040939. Epub 2010 Apr 2.

17.

Uracil DNA Glycosylase 2 negatively regulates HIV-1 LTR transcription.

Fenard D, Houzet L, Bernard E, Tupin A, Brun S, Mougel M, Devaux C, Chazal N, Briant L.

Nucleic Acids Res. 2009 Oct;37(18):6008-18. doi: 10.1093/nar/gkp673. Epub 2009 Aug 20.

18.

When is it time for reverse transcription to start and go?

Mougel M, Houzet L, Darlix JL.

Retrovirology. 2009 Mar 4;6:24. doi: 10.1186/1742-4690-6-24. Review.

19.

The conserved N-terminal basic residues and zinc-finger motifs of HIV-1 nucleocapsid restrict the viral cDNA synthesis during virus formation and maturation.

Didierlaurent L, Houzet L, Morichaud Z, Darlix JL, Mougel M.

Nucleic Acids Res. 2008 Aug;36(14):4745-53. doi: 10.1093/nar/gkn474. Epub 2008 Jul 18.

20.

Nucleocapsid mutations turn HIV-1 into a DNA-containing virus.

Houzet L, Morichaud Z, Didierlaurent L, Muriaux D, Darlix JL, Mougel M.

Nucleic Acids Res. 2008 Apr;36(7):2311-9. doi: 10.1093/nar/gkn069. Epub 2008 Feb 22.

Supplemental Content

Loading ...
Support Center